Remove 2019 Remove Physicians Remove Specialization
article thumbnail

Medical Devices Are Evolving Toward Specialized Solutions

MedCity News

As medical devices evolve and become more sophisticated, we are seeing a trend toward specialization. Building customized solutions for specialized disease states creates a nimbleness to respond to new conditions and develop a platform uniquely suited for that condition. It will become commonplace to see devices that break new ground.

article thumbnail

The Caregiver Vertical: How Pharma Engages

Pharma Marketing Network

Members of a multidisciplinary care team may include physicians, nurses, pharmacists, radiologists, dieticians…the list goes on. 2 In 2019, there were 7 potential family caregivers per older adult. Sunny’s healthcare marketing agency, Xavier Creative House, specializes in pharmaceutical, biotech, and medical device.

Pharma 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Competition is on the horizon for costly narcolepsy treatments

pharmaphorum

In order to bring it to market, a special program called Risk Evaluation and Mitigation Strategy (REMS) had to be put in place, where only eligible patients could access the drug through a very strict process. Harmony Biosciences introduced Wakix to the market in 2019 as the first non-controlled substance for the treatment of narcolepsy.

article thumbnail

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

Medgadget

Mark Toland, Medical Microinstruments: Microsurgery — the suturing of very small anatomy such as vessels (arteries and veins), ducts or nerves — requires high visual magnification and specialized precision instruments. Mark Toland: Symani received CE Mark in November 2019 and is commercially available in Europe.

Medical 109
article thumbnail

OIG’s Call for Increased Oversight of Remote Patient Monitoring Misses the Mark

Nixon Gwilt Law

The OIG Report: Key Findings The OIG indicates that this report was triggered in part by the rapid increase in Medicare claims for RPM between 2019 and 2022, with the number of enrollees using RPM services increasing more than tenfold during that time. The significant increase in claims from 2019 to 2022 is not a cause for concern.

article thumbnail

OIG’s Call for Increased Oversight of Remote Patient Monitoring Misses the Mark

Nixon Gwilt Law

The OIG Report: Key Findings The OIG indicates that this report was triggered in part by the rapid increase in Medicare claims for RPM between 2019 and 2022, with the number of enrollees using RPM services increasing more than tenfold during that time. The significant increase in claims from 2019 to 2022 is not a cause for concern.

article thumbnail

Four ways Biogen is tackling digital innovation in neurological disease

pharmaphorum

The explosion of data and innovation in healthcare has created problems for physicians, who can often have trouble keeping up with the medical literature. In 2019, he was awarded “Excellence in Medical Affairs Award” by the Association of Pharmaceutical Medicine Singapore (APMS). Building tools for clinicians. About Biogen.

Patients 137